Cleared Traditional

K892406 - MODIFIED OXYGEN DELIVERY/CO2 SAMPLE NAS...

K892406 is an FDA 510(k) clearance for MODIFIED OXYGEN DELIVERY/CO2 SAMPLE NAS..., manufactured by Salter Labs. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 108-day FDA review.

K892406 · Salter Labs · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1989
Decision
108d
Days
Class 2
Risk

K892406 is an FDA 510(k) clearance for the MODIFIED OXYGEN DELIVERY/CO2 SAMPLE NASAL CANNULA. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Salter Labs (Arvin, US). The FDA issued a Cleared decision on July 24, 1989 after a review of 108 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Salter Labs devices

FDA 510(k) Submission Details - K892406

510(k) Number K892406 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 07, 1989
Decision Date July 24, 1989
Days to Decision 108 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 140d · This submission: 108d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 152
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K892406.
OSCAROXY(TM) GAS MONITOR AND PULSE OXIMETER
K895780 · Datex Division Instrumentarium Corp. · Nov 1989
SALTER LABS MODEL #4009 SAMPLE LINES
K894350 · Salter Labs · Oct 1989
CAPNOMAC II(TM) ANESTHESIA MULTIGAS MONITOR
K891076 · Datex Division Instrumentarium Corp. · Aug 1989
BIOCHEM 520 BREATH INDICATOR
K890874 · Biochem International, Inc. · Jun 1989
ENGSTROM ELIZA + CO2 ANALYZER
K890112 · Gambro, Inc. · Mar 1989
NORMOCAP 200 CAPNOMETER
K882748 · Datex Division Instrumentarium Corp. · Oct 1988